[Diuretics for protection against hypertensive target-organ damage].
Hashimoto
Shigeatsu
S
Department of Internal Medicine 3, Fukushima Medical University School of Medicine.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007674:Kidney Diseases / Q000209:etiology / Q000517:prevention & control*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists